Piccirillo MC, Chu Q, Bradbury P, Seymour L, et al. Response to a Letter Received Entitled: "'Brief Report: Canadian Cancer Trials Group IND.227': Unpacking the Clinical Potential of Single-Agent Pembrolizumab in Advanced Malignant Pleural Mesothelioma". J Thorac Oncol 2023;18:e68-e69.
PMID: 37210189